Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Express Pharma: What COVID-19 taught us

Executive Director Jayasree K. Iyer joins a selection of specialists to "reflect on the biggest lessons for India Pharma Inc from the current pandemic." Viewpoints compiled by Lakshmipriya Nair with input from Usha Sharma.

Date

18 December 2020

Direct links

Read the full viewpoint

The COVID-19 pandemic brings a new perspective on our collective dependence on a fragile pharma industry. As part of this year-end edition for Express Pharma, Jayasree K. Iyer reflects on the ways that COVID-19 has underscored a need for access to medicine and vaccines for those living in low- and middle-income countries. Further, Iyer highlights "how India Pharma Inc can work with global health organisations to deliver to the most vulnerable populations, where others have failed to respond."

Click to read the full article on Express Pharma. 

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved